Chc Healthcare Group · TWSE:4164
Chc Healthcare — Investor Presentation (November 2024)
28 slides from Chc Healthcare's investor presentation, Nov 26, 2024
Slide 1: CHC Healthcare Group (4164) Investor Conference 2024/11/26
7K Se F Be (4164) 20245 2 Sa REARHS 2024/11/26 CSC axe
Slide 2: CHC Disclaimer
CSC z#+8 WHR AARE RR ARI AIRASI (LA PR REE Pitt > AICPA Bate RGUSRSEXSA > AREBHBSRA CSAS IEE + SHEE +s OER IEE > PEAT AR BAT -ZESPAERHE TR ° AXMPASRA EMEA CARAS > MRLBRMRERREBARA > Pins AAVA HRA > SORA ERAS HRA AA PM ERS BEE © ASSCHP RD AEE eS UME RR > Slee BAIR AS PAA ee BS SI AOR Ee SES RD + SPER
Slide 3: CNC a#t8
CNC a#t8
Slide 4: CNC a#t8
CNC a#t8
Slide 5: Company overview
• • 4164 • 2009 11 27 ( 1977 ) • • • • 1,668,451,490 • 2012 10 24
Slide 6: Elekta
CNC a#t8 eat HERS 70S EB ETERS JARS ake RERERAD RABE 201755 199755 197755. SADR Sa SPUlaHe SS BER SAr< UBS SRR HRSWER EERIE A tH BI SF HX OR ES SE HE i i HK CLUS SRAM K RSIS SE SHAGEEE - ERISA - RASA AS SAO MTR HAR SOS AWA Hee aS Peae Elekta {ugree eae (oO) RAR I
Slide 7: CHC business
CSC ae28 Ete 7 hd BAH EARS ED RRAR SE aici)
Slide 8: Partner brands
CNC a#t8 BS] Bem A a Tas ne fh A SP Maes HARES A ARF} ES 4 — re s G 3 aoa AIA EBER “a @ MICROSYSTEMS BRON vcs Prw IMRIS as ® BVI WUNYS Bd MEGIN Decree an ELEKTA Compa nowNjun %<f Ashland ny ECOLAB CASCcINATIONS Eanes Qoreerarne *plasmapp ALBOMED = @microresVC-RAD Klarity PXORUGISSN Swissray"- We oei
Slide 9: CNC ae28
CNC ae28 BAU ARS Bate eS She RA Ate BSR ae ERAS DEAR a FS fH PR Aa LRM — well _ —_—
Slide 10: CSC a##8
CSC a##8 SACS Eke - ERR wiaw f£ - — = A = g \ 3 sw Ed BS Rave 71 Fle r \ wan J | a c a » | R ke } “4 . #ELEeRE Rts BEER EE EL : BAH a/R - SFR RRR as &< 4 £ X —-a7 m> AOSB ITE 2G aon oo a oo ao
Slide 11: 30% of energy savings
CSC a##8 Ww ay ate = al Ty) 30% of energy savings a BER @
Slide 12: CNC a#t8
CNC a#t8
Slide 13: Revenue chart 2019-2024
( ) 5,000,000 3,877,137 4,000,000 2,974,352 3,127,735 2,950,052 2,816,643 3,000,000 2,554,911 2,439,564 2,000,000 1,000,000 - 2019 2020 2021 2022 2023 2023 1~10 2024 1~10 ( ) ( )
Slide 14: ORE OBER MBA
CNC a#t8 ORE OBER 9 MBA
Slide 15: EBITDA
( ) EBITDA ( ) 1,500,000 5 1,231,233 1,200,000 4 1,001,839 1,042,109 956,752 970,340 900,000 802,628 3 2.83 674,175 600,000 2.53 2.43 2.55 2 2.21 300,000 1.33 1 0.74 0 0 390,431 362,912 380,282 388,650 425,238 226,643 120,511 2019 2020 2021 2022 2023 2023 2024
Slide 16: ( ) 2.5 100% ( ) ( ) 80% 2019 2.83 71% 1.5 60%
( ) 2.5 100% ( ) ( ) 2 80% 2019 2 2.83 71% 1.5 60% 2020 2.01 2.53 79% 1 40% 2021 2.011 2.43 83% 2022 2.01 2.21 91% 0.5 20% 2023 2.01 2.55 79% 0 0% 2019 2020 2021 2022 2023
Slide 17: CNC a#t8
CNC a#t8
Slide 18: Elekta
CNC a#t8 PERSE - Elekta Ri HRB Ae RS asic) So) Elekta 7 Elekta Unity
Slide 19: IBA
- IBA 40+% MARKET SHARE 75+ PROTON CENTERS 130,000+ PATIENTS IN PROTON THERAPY POWERED BY IBA TREATED ON IBA EQUIPMENT
Slide 20: Baxter
CNC a#t8 ERR ER - BaxteriE XA FiRRAR Baxter Ko)
Slide 21: BVI
CSC a##8 HER ia em - BVI= EAE TERICA Lk Gods s@ BVI @evi y FINEVISION HP @ OL ) | GFY @evi Market Leading Portfolio of RESON ae Ophthalmic Surgical Devices
Slide 22: fiaA GE
fiaA GE 80 60 40 20 CNC a#t8 Ree - ER Hiss Pie Rees ce ee BNE re 20085 2012 20165 20205 2024 (@2 8a) — RS
Slide 23: Process steps
CNC a#t8 ae aR PAS Se STEP STEP STEP 01 02 03 04 05 06 07 Pepe rd sen © sane @Q@ ore Q@ exec QO we @® seu @® enue (E-Beam & X-Ray) .-..) = — ig. [} =e wA ee a” 2 STEP ‘STEP ‘STEP ‘STEP STEP STEP STEP 01 02 03 04 05 06 07 =] &% 5 ape oes > ~ > | nx > & > |=} > > 1@ RS GS tm > |G Ep ? 0 Sa Ramee Wet E
Slide 24: CNC a#t8
CNC a#t8
Slide 25: Neutron Therapeutics
CSC a##8 5 | EWA HRIEIS I - Neutron Therapeutics *% neutron ‘€therapeutics
Slide 26: Application areas
• 消滅微生物 • 消滅細菌 • 抑制食材發芽 食材 醫療 • 確保無菌 • 降低感染風險 • 延長食品保鮮期 應用 領域 • 半導體切換效率提升 • 輻射交聯聚合物 • 材料改性 材料 其他 • 航太材料耐受性測試 • 寶石顏色增強 • 強化複合材料 • 郵政郵件淨化…
Slide 27: Contact
CNC a#t8 RARREX abs Bees FRR RE (410038) {ETE TUS (300K) BEBE (A100)
Slide 28: Thank you!
Thank you! www.chcg.com Copyright © 2019 CHC Limited. All rights reserved.
CHC Healthcare Group — Investor Presentation (November 2024) on 6ix